Reference card
MTAP testing quick reference
One-page summary of IHC, FISH, and NGS approaches with interpretation cutoffs.
Request access
Reading list
Key MTAP & PRMT5 literature
Curated foundational papers on the synthetic lethal relationship and recent clinical updates.
Request access
Case discussion
Molecular tumor board templates
Discussion prompts and reporting templates for surfacing MTAP findings in MTB.
Request access
Patient handout
What MTAP means — for patients
Plain-language explainer to share with patients whose tumors carry MTAP loss.
Request access
ClinicalTrials.gov
Search active and completed trials referencing MTAP status.
cBioPortal
Explore MTAP deletion frequencies across published genomic datasets.
CAP Molecular Pathology
Reference standards for molecular and copy-number testing in solid tumors.
BMS Clinical Trials
Investigator-sponsored and industry-sponsored trial directory.
Stay current
Sign up for MTAP educational updates.
New literature, evolving guidelines, and trial milestones — no promotional content.
Clinical trials
When testing reveals an MTAP deletion, a trial may be the next conversation.
Investigational PRMT5 inhibitors are being studied in patients whose tumors carry homozygous MTAP loss. Refer eligible patients early — site activation, screening, and consent take time.
Search the trial directory